首页 | 本学科首页   官方微博 | 高级检索  
检索        

以蟾蜍为主中药在治疗慢性粒细胞白血病-加速期的疗效
引用本文:陈江声,杨燕娇.以蟾蜍为主中药在治疗慢性粒细胞白血病-加速期的疗效[J].河北医学,2006,12(11):1133-1134.
作者姓名:陈江声  杨燕娇
作者单位:汕头大学医学院第二附属医院,广东,汕头,515041;汕头大学医学院第二附属医院,广东,汕头,515041
摘    要:目的:探讨以蟾蜍为主的中药在治疗慢性粒细胞白血病-加速期的疗效。方法:63例慢性粒细胞白血病(CML)在进入加速期后,分别用原化疗方案加用以蟾蜍为主中药治疗(A组,n=35)和DA或HA方案化疗(B组,n=28)。结果:A组22例治疗成功,占62.9%;B组21例成功,占75%。两组疗效的差别无统计学意义,P>0.05。两组间副作用的差别有统计学意义,P<0.05。结论:以蟾蜍为主的中药对慢性粒细胞白血病-加速期可能有效。

关 键 词:慢性粒细胞白血病-加速期  中药  疗效
文章编号:1006-6233(2006)11-1133-02

The Effect of Traditional Chinese Medicine in Treating Chronic Myelogenous Leukemia-accelerating Phase
CHEN Jiang-sheng,YANG Yan-jiao.The Effect of Traditional Chinese Medicine in Treating Chronic Myelogenous Leukemia-accelerating Phase[J].Hebei Medicine,2006,12(11):1133-1134.
Authors:CHEN Jiang-sheng  YANG Yan-jiao
Institution:The Second Affiliated Hospital ,Shantou University of Medical College, Guangdong Shantou 515041, China
Abstract:Objective:To discuss the traditional Chinese medicine on chronic myelogenous leukemia-accelerating phase.Method:63 patients with chronic myelogenous leukemia-accelerating phase were treated with original plan and the traditional Chinese medicine(A group,n=35) and B group with DA or HA plan(n=28).Result: The curative rate of the A group was 62.9%;the B group was 75%.The difference of curative rate and uncurative rate in two groups were no statistics significant,P>0.05.The side effect of two groups were significant,P<0.05.Conclusion: The traditional Chinese medicine may be effective in treating chronic myelogenous leukemia-accelerating phase.
Keywords:Chronic myelogenous leukemia  Chinese traditional medicine  Effect
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号